When the Genetic Test You Assumed Was Done During Surgery Turns Up as a Separate Bill — Where NGS Testing Splits Into Covered, Partially Covered, and Uncovered, and What to Check Before Filing an Insurance Claim

A surgical pathology report lists the tumor type, the stage, and the status of the resection margins. When a few gene names appear alongside those findings, it is easy to assume that genetic testing has already been completed. But immunohistochemistry (IHC) and single-gene assays, which commonly appear on a pathology report, are different from a next-generation sequencing (NGS) panel that reads dozens to hundreds of genes at once. NGS usually requires a separate order and consent form, along with an adequate sample of tumor tissue or blood. That is why the test does not automatically follow on from surgery, even when the surgical specimen is still stored at the hospital.

Several factors explain why the same test costs different amounts for different people. The first is how national health insurance treats it: depending on the cancer type, stage, presence of metastasis, and prior treatment history, the test may be fully covered, covered with a high patient co-payment rate, or not covered at all. These criteria are revised over time, so what someone else paid last year may not match your situation this year. The second is the scope of the panel — a small panel of a few genes, a large comprehensive panel, tissue-based testing, or a blood-based liquid biopsy. The third is timing, since testing at initial diagnosis and repeat testing after progression or recurrence are billed separately. The fourth is the price variation between hospitals for services that fall outside insurance coverage.

The point that most often causes confusion with private indemnity health insurance is that a hospital's administrative classification and the classification written into an insurance policy are not necessarily the same. When a patient receiving chemotherapy is registered as a same-day admission in a day-care unit, that reflects how the treatment fee is calculated under national health insurance. An insurer, by contrast, applies the definitions written in its own policy, which typically consider whether admission was clinically necessary and whether there was meaningful time under staff observation and care. Differences between policy generations, per-visit outpatient limits, and co-payment rates for uncovered items all add further variation. Dates matter too: if the day the test was ordered, the day the sample was taken, the day results were reported, and the day payment was made are all different, it affects which encounter the cost is attached to.

A practical order of preparation helps before filing. First, request the itemized statement of medical expenses rather than the receipt alone, and confirm the exact item name and coverage category of the test. Second, check whether the test charge was billed on the same date as the day-care visit or on a different date. Third, ask the administrative office whether the encounter produces an admission and discharge certificate or only an outpatient visit certificate. Fourth, ask the treating team whether the clinical reason for the test and its role in treatment planning can be documented in a medical opinion or in the chart. Fifth, contact the insurer in advance with the policy number and enrollment date, and note the answer and the date of the call. Sixth, if the claim is denied or only partly paid, ask for the reason in writing rather than verbally, and check the available appeal or dispute-mediation routes.

Separately from cost and reimbursement, it is worth clarifying what the result will be used for. NGS findings can inform consideration of targeted therapy or eligibility for a clinical trial, but not everyone will have an actionable alteration, and even when one is found, whether a matched drug is approved or reimbursed is a further question. Discussing the intended use of the result in the clinic beforehand helps set realistic expectations about the waiting time and the expense.

This article is general information and does not replace individual medical care or the interpretation of an insurance policy. Please discuss the need for and timing of testing with your treating clinicians, and questions about reimbursement with your insurer and policy documents.